前列腺癌中的BRCA种系突变：未来是个性化的。
BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored.
作者信息
Crocetto Felice, Barone Biagio, Caputo Vincenzo Francesco, Fontana Matteo, de Cobelli Ottavio, Ferro Matteo
机构信息
Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples "Federico II", 80131 Naples, Italy.
Division of Urology, European Institute of Oncology, IRCSS, Milan, Via Ripamonti 435, 20141 Milan, Italy.
出版信息
Diagnostics (Basel). 2021 May 19;11(5):908. doi: 10.3390/diagnostics11050908.
Abstract
Prostate cancer (PCa) is the second most common neoplasm in men and the fifth leading cause of death worldwide [...].
摘要
前列腺癌（PCa）是男性中第二常见的肿瘤，也是全球第五大死因[……]。
相似文献
1
BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored.前列腺癌中的BRCA种系突变：未来是个性化的。
Diagnostics (Basel). 2021 May 19;11(5):908. doi: 10.3390/diagnostics11050908.
2
Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.种系 DNA 修复基因突变与一线接受阿比特龙和恩杂鲁胺治疗的转移性去势抵抗性前列腺癌男性的结局
Eur Urol. 2018 Aug;74(2):218-225. doi: 10.1016/j.eururo.2018.01.035. Epub 2018 Feb 10.
3
Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.疑似遗传性癌症综合征和种系突变在报告前列腺癌家族史的不同队列中的先证者中的流行率：为男性的级联检测提供信息。
Eur Urol Oncol. 2020 Jun;3(3):291-297. doi: 10.1016/j.euo.2019.06.010. Epub 2019 Jul 3.
4
Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screening.基于影像学的 BRCA 突变携带者前列腺癌筛查 - 首轮筛查结果。
Ann Oncol. 2020 Nov;31(11):1545-1552. doi: 10.1016/j.annonc.2020.06.025. Epub 2020 Sep 18.
5
[Risk-adapted prostate cancer screening-update 2021].[风险适应性前列腺癌筛查——2021年更新]
Urologe A. 2021 May;60(5):592-601. doi: 10.1007/s00120-021-01505-9. Epub 2021 Apr 1.
6
Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer.胚系 DNA 修复基因罕见致病性突变与 5 级分组前列腺癌关系最密切。
Eur Urol Oncol. 2020 Apr;3(2):224-230. doi: 10.1016/j.euo.2019.12.003. Epub 2020 Jan 14.
7
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.胚系 BRCA 突变表示前列腺癌的一种临床病理亚组。
Clin Cancer Res. 2010 Apr 1;16(7):2115-21. doi: 10.1158/1078-0432.CCR-09-2871. Epub 2010 Mar 9.
8
Role of BRCA Mutations in the Modulation of Response to Platinum Therapy.BRCA突变在调节铂类治疗反应中的作用。
Front Oncol. 2018 Feb 5;8:16. doi: 10.3389/fonc.2018.00016. eCollection 2018.
9
Bringing Prostate Cancer Germline Genetics into Clinical Practice.将前列腺癌种系遗传学带入临床实践。
J Urol. 2019 Aug;202(2):223-230. doi: 10.1097/JU.0000000000000137. Epub 2019 Jul 8.
10
Germline breast cancer susceptibility gene mutations and breast cancer outcomes.胚系乳腺癌易感性基因突变与乳腺癌结局。
BMC Cancer. 2018 Mar 22;18(1):315. doi: 10.1186/s12885-018-4229-5.
引用本文的文献
1
From infection to tumor: genetic evidence of viral antibody immune response' role in urologic cancer development.从感染到肿瘤：病毒抗体免疫反应在泌尿系统癌症发展中作用的遗传学证据
Discov Oncol. 2025 May 29;16(1):947. doi: 10.1007/s12672-025-02768-w.
2
Clinical Predictors and Risk Factors of Gleason Score Upgrade: A Retrospective Cohort Analysis.Gleason评分升级的临床预测因素和风险因素：一项回顾性队列分析
Diagnostics (Basel). 2025 May 14;15(10):1238. doi: 10.3390/diagnostics15101238.
3
Impact of Nerve-Sparing Techniques on Prostate-Specific Antigen Persistence Following Robot-Assisted Radical Prostatectomy: A Multivariable Analysis of Clinical and Pathological Predictors.保留神经技术对机器人辅助根治性前列腺切除术后前列腺特异性抗原持续存在的影响：临床和病理预测因素的多变量分析
Diagnostics (Basel). 2025 Apr 13;15(8):987. doi: 10.3390/diagnostics15080987.
4
Clinical and Genomic Features of Androgen Indifferent Prostate Cancer.雄激素不敏感型前列腺癌的临床和基因组特征
Int J Mol Sci. 2025 Jan 15;26(2):679. doi: 10.3390/ijms26020679.
5
Identification and validation of CDK1 as a promising therapeutic target for Eriocitrin in colorectal cancer: a combined bioinformatics and experimental approach.鉴定和验证细胞周期蛋白依赖性激酶1（CDK1）作为橙皮苷治疗结直肠癌的潜在治疗靶点：生物信息学与实验相结合的方法
BMC Cancer. 2025 Jan 13;25(1):76. doi: 10.1186/s12885-025-13448-x.
6
Construction of a clinically significant prostate cancer risk prediction model based on traditional diagnostic methods.基于传统诊断方法构建具有临床意义的前列腺癌风险预测模型。
Front Oncol. 2024 Dec 20;14:1474891. doi: 10.3389/fonc.2024.1474891. eCollection 2024.
7
Colorectal cancer with a germline BRCA1 variant inherited paternally: a case report.一例父系遗传的携带种系BRCA1变异的结直肠癌病例报告。
J Pathol Transl Med. 2024 Nov;58(6):341-345. doi: 10.4132/jptm.2024.08.14. Epub 2024 Sep 5.
8
Endoplasmic reticulum stress-related genes as prognostic and immunogenic biomarkers in prostate cancer.内质网应激相关基因作为前列腺癌的预后和免疫原性生物标志物。
Eur J Med Res. 2024 Apr 20;29(1):242. doi: 10.1186/s40001-024-01818-3.
9
Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients.中国前列腺癌患者队列中与 HPV 感染状态相关的基因组改变。
Eur J Med Res. 2023 Jul 17;28(1):239. doi: 10.1186/s40001-023-01207-2.
10
High monoamine oxidase a expression predicts poor prognosis for prostate cancer patients.高单胺氧化酶 A 表达预示前列腺癌患者预后不良。
BMC Urol. 2023 Jul 4;23(1):112. doi: 10.1186/s12894-023-01285-8.
本文引用的文献
1
Diagnostic Strategies for Treatment Selection in Advanced Prostate Cancer.晚期前列腺癌治疗选择的诊断策略
Diagnostics (Basel). 2021 Feb 19;11(2):345. doi: 10.3390/diagnostics11020345.
2
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings.转移性去势敏感型前列腺癌的一线系统治疗：一项具有新发现的更新系统评价。
Crit Rev Oncol Hematol. 2021 Jan;157:103198. doi: 10.1016/j.critrevonc.2020.103198. Epub 2020 Dec 13.
3
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations.铂类化疗在伴有和不伴有 DNA 修复基因异常的晚期前列腺癌患者中的活性。
JAMA Netw Open. 2020 Oct 1;3(10):e2021692. doi: 10.1001/jamanetworkopen.2020.21692.
4
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a or Gene Alteration.芦卡帕利治疗携带 或 基因改变的转移性去势抵抗性前列腺癌男性患者的疗效。
J Clin Oncol. 2020 Nov 10;38(32):3763-3772. doi: 10.1200/JCO.20.01035. Epub 2020 Aug 14.
5
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis.雄激素受体轴靶向治疗在转移性去势敏感前列腺癌患者中的疗效预测因素：系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2020 Jul;151:102992. doi: 10.1016/j.critrevonc.2020.102992. Epub 2020 May 23.
6
Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients.男性乳腺癌：多基因检测在意大利患者队列中的应用结果
Diagnostics (Basel). 2020 Apr 30;10(5):269. doi: 10.3390/diagnostics10050269.
7
Olaparib for Metastatic Castration-Resistant Prostate Cancer.奥拉帕利治疗转移性去势抵抗性前列腺癌。
N Engl J Med. 2020 May 28;382(22):2091-2102. doi: 10.1056/NEJMoa1911440. Epub 2020 Apr 28.
8
Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study.男性 BRCA1 和 BRCA2 基因突变携带者的前列腺癌风险：一项前瞻性队列研究。
Eur Urol. 2020 Jan;77(1):24-35. doi: 10.1016/j.eururo.2019.08.025. Epub 2019 Sep 6.
9
From Targeting Somatic Mutations to Finding Inherited Cancer Predispositions: The Other Side of the Coin.从靶向体细胞突变到发现遗传性癌症易感性：硬币的另一面。
Diagnostics (Basel). 2019 Jul 26;9(3):83. doi: 10.3390/diagnostics9030083.
10
Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.前列腺癌种系变异的流行情况及其对当前遗传检测指南的影响。
JAMA Oncol. 2019 Apr 1;5(4):523-528. doi: 10.1001/jamaoncol.2018.6760.
Zotero 插件